Les Laboratoires Servier and Another v Apotex Inc. and Others

JurisdictionEngland & Wales
JudgeLord Justice Jacob,Sullivan LJ,Sir David Keene
Judgment Date12 February 2010
Neutral Citation[2010] EWCA Civ 279
Docket NumberCase No: A3/2008/2867 & 2867(B)
CourtCourt of Appeal (Civil Division)
Date12 February 2010

[2010] EWCA Civ 279

IN THE COURT OF APPEAL (CIVIL DIVISION)

ON APPEAL FROM THE HIGH COURT OF JUSTICE

CHANCERY DIVISION, PATENT COURT

MR JUSTICE NORRIS

Royal Courts of Justice

Strand, London, WC2A 2LL

Before:

Lord Justice Jacob

Lord Justice Sullivan

and

Sir David Keene

Case No: A3/2008/2867 & 2867(B)

Between:
Les Laboratoires Servier & ANR
Appellant
and
Apotex Inc & Ors
Respondent

Mr Iain Purvis QC and Mr Andrew Lykiardopoulos (instructed by Bristows) appeared on behalf of the Appellant.

Mr Anthony Watson QC and Mr Colin Birss QC (instructed by Messrs Taylor Wessing) appeared on behalf of the Respondent.

(As Approved)

Lord Justice Jacob
1

This is an appeal from a decision of Norris J given on 9 October 2008. In June 2008 over a period of five days he heard an inquiry as to what damages if any should be paid to the parties (whom I will call "Apotex") who had been the subject of an interlocutory injunction for a period of 11 months before the patent was held to be invalid by Pumfrey J, a decision confirmed with considerable emphasis by a decision of this court. The patent was one that should never have been granted, not through the fault of the Patent Office, but because the patentees must have known that it was invalid.

2

Norris J had to wade through masses of accountancy and other evidence and had come to the conclusion that the appropriate sum payable was £17.5 million. No-one suggests that he got his calculations wrong. But shortly before he gave his judgment and after all the evidence and argument had taken place, Servier made an application to amend its pleadings. It came about in this way. The Apotex product was made in Canada, or would have been made in Canada, where Apotex's headquarters are. A cross-undertaking had been given at the interlocutory stage not only to the United Kingdom Apotex company but also to a number of other Apotex companies including the Canadian company. Apotex had learnt from past experience that you need such a cross-undertaking if you are to be able to claim any damages if it turns out the injunction is wrongly granted.

3

As I say, Servier made an application. The basis of the application was that the Federal Court in Canada had held that the manufacture in Canada of the material, perindopril, was an infringement of the Canadian patent. It was not the same patent or corresponding patent to that which had been the subject of the English proceedings. It was the basic patent for perindopril, not merely a crystalline form of it. We were told that under some quirk of Canadian law the basic patent can last a very long time indeed, and on 2 July the Federal Court held the patent valid and infringed in Canada. It followed that the perindopril which would have been supplied to the United Kingdom would have been made in infringement of the Canadian patent.

4

Servier asked the judge for leave to amend its pleadings to put forward two distinct defences: firstly, one essentially of law, that Apotex could not claim damages for being prevented to sell a material whose manufacture would have been unlawful; secondly, more as an accounting matter, Apotex Canada could not claim that it would have...

To continue reading

Request your trial
8 cases
  • Les Laboratoires Servier v Apotex Inc.
    • United Kingdom
    • Chancery Division (Patents Court)
    • 29 March 2011
    ...Court of Appeal against Norris J's refusal of its amendment application. On 12 February 2010 the Court of Appeal allowed the appeal ([2010] EWCA Civ 279). In his judgment Jacob LJ, with whom Sullivan LJ and Sir David Keene agreed, held at [7] that Norris J had not exercised his discretion ......
  • Les Laboratoires Servier v Apotex Inc.
    • United Kingdom
    • Supreme Court
    • 29 October 2014
    ...and directed that Norris J's award of damages should be treated as an interim order pending determination of the new issues: [2010] EWCA Civ 279. 8 Subsequently, Lewison J made an order staying the second of the new issues (the cost of manufacture issue) until damages had been assessed in ......
  • Twentieth Century Fox Film Corporation and Others v David Harris and Others
    • United Kingdom
    • Chancery Division
    • 5 February 2013
    ...Copyright Act 1956 is noteworthy in this context. As Arnold J explained in Les Laboratoires Servier v Apotex Inc [2011] EWHC 730 (Pat), [2011] RPC 20 (at paragraph 67): "S.18 of the 1956 Act created a statutory fiction that infringing copies of copyright works were deemed to belong to the ......
  • Les Laboratoires Servier v Apotex Inc.
    • United Kingdom
    • Court of Appeal (Civil Division)
    • 3 May 2012
    ...to the Canadian defendant Apotex Inc and ten per cent. was apportioned to Apotex UK Limited. The Court of Appeal subsequently held ( [2010] EWCA Civ 279) that sum should stand as an interim payment pending the determination of new defences to be advanced by Servier. Servier re-amended its ......
  • Request a trial to view additional results
1 books & journal articles
  • Management and Enforcement
    • Canada
    • Irwin Books Intellectual Property Law. Second Edition
    • 15 June 2011
    ..., [2006] EWCA Civ 658 [ Smithkline ]; Les Laboratories Servier v. Apotex Inc. , [2008] EWHC 2347 at [10] (Ch.), rev’d on other grounds [2010] EWCA Civ 279 (equitable compensation should be “liberally” assessed) [ Servier ]; Merck Frosst , above note 269 (stay under Patent Medicines (Notice ......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT